Literature DB >> 6324840

5'-Nucleotidase activity and arachidonate metabolism in doxorubicin sensitive and resistant P388 cells.

A Ramu, D Glaubiger, P Soprey, G H Reaman, N Feuerstein.   

Abstract

5'-nucleotidase activity, arachidonate metabolism and adenosine uptake were measured in P388 murine leukaemia cells and in a subline resistant to doxorubicin. These membranes related activities were found to be increased in the doxorubicin resistant cell line, compared to the drug sensitive cells. It is suggested that these differences do not play a role in the mechanism of resistance to doxorubicin. Rather they reflect alterations in plasma membrane composition and structure between these cell lines. This study also suggests that the use of decreased 5'-nucleotidase activity as a marker of certain leukaemias should be reviewed with caution. An increase in cell enzyme activity in treated patients may not necessarily indicate a shift toward normal behaviour of these cells, but rather a selection of certain cell subpopulations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324840      PMCID: PMC1976773          DOI: 10.1038/bjc.1984.71

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  Studies on the lymphocyte 5'-nucleotidase in chronic lymphocytic leukemia, infectious mononucleosis, normal subpopulations, and phytohemagglutinin-stimulated cells.

Authors:  F Quagliata; D Faig; M Conklyn; R Silber
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

2.  Evidence for a 5'-nucleotidase in human leukemic leukocytes.

Authors:  D Marique; J Hildebrand
Journal:  Clin Chim Acta       Date:  1973-04-19       Impact factor: 3.786

3.  Heterogeneity of 5'-nucleotidase activity in lymphocytes in chronic lymphocytic leukemia.

Authors:  J Lopes; D Zucker-Franklin; R Silber
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

4.  Inhibition of the nucleotidase effect of alkaline phosphatase by beta-glycerophosphate.

Authors:  A Belfield; D M Goldberg
Journal:  Nature       Date:  1968-07-06       Impact factor: 49.962

5.  Altered glycosidase levels in drug-resistant mouse leukemias.

Authors:  H B Bosmann; D Kessel
Journal:  Mol Pharmacol       Date:  1970-07       Impact factor: 4.436

6.  Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).

Authors:  R K Johnson; A A Ovejera; A Goldin
Journal:  Cancer Treat Rep       Date:  1976-01

7.  Radioimmunoassays for prostaglandin metabolites.

Authors:  E Granström; H Kindahl
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

8.  Changes in (Na+ + K+)-ATPase activity of Ehrlich ascites tumor cells produced by alteration of membrane fatty acid composition.

Authors:  L P Solomonson; V A Liepkalns; A A Spector
Journal:  Biochemistry       Date:  1976-02-24       Impact factor: 3.162

9.  Modification of adenylate cyclase activity in LM cells by manipulation of the membrane phospholipid composition in vivo.

Authors:  V H Engelhard; J D Esko; D R Storm; M Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

10.  Uptake as a determinant of methotrexate response in mouse leukemias.

Authors:  D Kessel; T C Hall; D Roberts; I Wodinsky
Journal:  Science       Date:  1965-11-05       Impact factor: 47.728

View more
  2 in total

1.  Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.

Authors:  D Roberts; T Lee; E Parganas; L Wiggins; J Yalowich; R Ashmun
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.

Authors:  A Ramu; R Spanier; H Rahamimoff; Z Fuks
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.